D5W is used as an IV solution in hospitals worldwide. Being mostly a subcutaneous treatment and using only a 1/2 inch needle, harm is minimised
Every treatment aims to extinguish the pain. After the first treatment pain relief may last for a period of 4 hours to 4 days. Repeated treatments (6-8 sessions) usually done weekly, result in a gradual reduction of the overall pain, with the aim of complete resolution
The treatment consists of a series of small injections immediately under the skin targeting painful areas where the nerves are sensitive, with non-pharmacological ingredients. The substance Dr Lyftogt uses is a buffered D5W (dextrose 5% in sterile water) with a neutral pH of 7.4
In 1906 the importance of small unmyelinated C-fibres in the pain experience was discovered by Prof. Charles Sherrington in England.
In 2010 an effective treatment for pain caused by C-fibres was discovered by John Lyftogt, MD, in New Zealand. Dr Lyftogt was the first person to use D5W (dextrose 5% in sterile water) to treat painful nerves and inhibit chronic neuropathic pain.
Over 3,500 Practitioners throughout the world have learned Lyftogt PIT®. Join them, and become the Practitioner you want to be.
Purchase videos of Dr. John Lyftogt teaching a 3-day Introductory workshop or treating patients with Lyftogt PIT® at Master Classes
“ I started using PIT in the emergency departments where I worked at the time. The results were remarkable. A new way of approaching pain and dysfunction was borne in my mind. John helped me to swallow the big pill of adopting a new paradigm, and unlearning a lot of what I had absorbed in my conventional medicine training. Thanks to the teaching, encouragement and mentorship of Dr. Lyftogt, I now have two integrative and regenerative practices and have helped countless people using PIT. ”
“ Lyftogt Perineural Injection Treatment is an essential part of my musculoskeletal medicine practice. It is a remarkable treatment that provides immediate and sustained pain relief and restored function in both acute and chronic musculoskeletal pain settings. The technique is simple and effective and can provide outstanding results. ”
“ I use PIT as my initial go-to method for treating most musculoskeletal pain because it is safe, rapidly effective, well-tolerated, and gives immediate feedback. ”
“ Yo amo PIT porque es un tratamiento simple, seguro, accesible,pero sobre todo MUY efectivo. Ha cambiado mi forma de ver a las personas con dolor, siento que realmente los puedo ayudar. ”
“ PIT is a fast and effective tool for removing and healing people of acute and chronic pain. A simple procedure that dramatically improves pain levels immediately in the office builds over time to support regeneration of nerves and proper function of joints and muscles. I personally will never practice again without this tool. ”
“ I today wouldn't have had the success that I am having in many patients suffering with chronic pain without PIT. I love to treat patients and I am addicted to the smile and success. Thanks to PIT, I am able to help thousands of people. I have an average of 40 patients a week with chronic pain, so I needed this excellent treatment option. ”
"I love the patient's face when they are pain free with P.I.T."
“ I like PIT because it is steroid-free, lidocaine-free and pain-free. PIT helps the patients to feel the sweet of life!”
“ I find Peri-neural glucose injections a powerful, and at times life changing, treatment modality for patients who suffer from chronic musculoskeletal and neuropathic pain syndromes. ”
“ PIT is a highly effective treatment for neuropathic pain and fibromyalgia, risk free, affordable and, in few words, just amazing. I get to treat musculoskeletal pain in athletes as well as in elderly patients with results as good as permanent pain free in 85% of the cases. It has absolutely changed my practice. ”
It is hoped that in-person educational events taught by Dr. John Lyftogt, including workshops and Master Classes, will resume in 2022. This year there are plans for events in New Zealand and Australia and possibly North America and beyond, depending upon Covid-19 and associated border entry restrictions.
FIND OUT MORE
